Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pan Afr Med J ; 46: 79, 2023.
Artigo em Francês | MEDLINE | ID: mdl-38282778

RESUMO

Introduction: men who have sex with men (MSM) are disproportionately affected by hepatitis B virus (HBV) and hepatitis C virus (HCV) worldwide. In Benin, there are no data on MSM. The purpose of this study was to estimate HBV and HCV prevalence and HBV-associated factors in MSM who were HIV negative. Methods: we conducted an analytical cross-sectional study. A two-degree random sampling was used to recruit 204 MSM. An immunochromatographic rapid test and enzyme immunoassays were used to detect HBV and HCV antigens/antibodies. Log-binomial regression was used to identify factors associated with HBV. Results: HbsAg positivity, history of hepatitis B infection and hepatitis C prevalences were 37.7%, 8.8 %, and 0.9 %, respectively. HBsAg positivity and history of hepatitis B were more prevalent in MSM aged ≥30 years compared to younger subjects: 16.7% versus 6.4% (p<0.0001) and 66.7% versus 28.8% (p<0.0001), respectively. Sexual intercourse under the effect of drug or alcohol and living in couple were also associated with HBV. conclusion: the prevalence of hepatitis C was low, but hepatitis B was common, especially among older MSM. Screening and vaccination against hepatitis B should be strengthened in this population.


Assuntos
Infecções por HIV , Hepatite B , Hepatite C , Profilaxia Pré-Exposição , Minorias Sexuais e de Gênero , Masculino , Humanos , Homossexualidade Masculina , Prevalência , Antígenos de Superfície da Hepatite B , Infecções por HIV/epidemiologia , Infecções por HIV/complicações , Coito , Estudos Transversais , Benin/epidemiologia , Hepatite B/epidemiologia , Hepatite B/prevenção & controle , Hepatite B/complicações , Hepatite C/epidemiologia , Hepatite C/prevenção & controle , Hepatite C/complicações , Vírus da Hepatite B , Hepacivirus , Anticorpos Anti-Hepatite C
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA